Ilovebenefits’s Blog

Just another WordPress.com weblog

Comparative Effectiveness – The First Act

FDA Eyes Setting Up Two CER Centers To Leverage Agency Data
Even though FDA does not have explicit statutory authority to mandate that new products are superior to legacy medical interventions, the new centers would provide the agency with strategies to potentially incorporate CER into its new life-cycle approach to regulating health care products. [ Inside Health Reform | Mar 11,

Advertisements

March 11, 2010 - Posted by | healthcare, quality, Research | ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: